Literature DB >> 23250340

Evaluating the level of pain during office hysteroscopy according to menopausal status, parity, and size of instrument.

Péter Török1, Tamás Major.   

Abstract

INTRODUCTION: The aim of the study was to evaluate the factors that may affect experienced pain during office hysteroscopy performed without anesthesia in an outpatient setting.
MATERIALS AND METHODS: We enrolled the patients into six groups, differentiated by parity, menopausal status and type of the sheath that was used for the examination. During office hysteroscopy the pain score was recorded using a visual analog scale.
CONCLUSION: Statistical analysis of the results revealed no evidence that parity, menopausal status, or the thickness of the instrument influence the level of experienced pain.

Entities:  

Mesh:

Year:  2012        PMID: 23250340     DOI: 10.1007/s00404-012-2667-x

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  3 in total

1.  Diclofenac Potassium Alone Versus Diclofenac Potassium with Hyoscine-N-butyl Bromide (HBB) in Reduction of Pain in Women Undergoing Office Hysteroscopy: A Double Blind Randomized, Placebo-Controlled Trial.

Authors:  Ahmed S S A Rashwan; Mahmoud Alalfy; Sarah Aboubakr Elkomaty; Omneya Mostafa Helal; Eman Aly Hussein
Journal:  J Obstet Gynaecol India       Date:  2022-04-13

2.  Is every patient eligible to have an office hysteroscopy? A retrospective analysis of 1301 procedures.

Authors:  Magdalena M Biela; Jacek Doniec; Monika Szafarowska; Kamil Sobocinski; Andrzej Kwiatkowski; Paweł Kamiński
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-11-05       Impact factor: 1.195

3.  Impact of anxiety levels on the perception of pain in patients undergoing office hysteroscopy.

Authors:  Felice Sorrentino; Annamaria Petito; Stefano Angioni; Francesco D'Antonio; Melania Severo; Maria Cristina Solazzo; Raffaele Tinelli; Luigi Nappi
Journal:  Arch Gynecol Obstet       Date:  2020-11-19       Impact factor: 2.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.